Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes.

× No keyword cloud information.

15 in total

1. Role of B cells in presentation of autoantigens to CD4(+) T cells in patients with autoimmune thyroiditis.

Authors: E M Kuklina; E N Smirnova; I V Nekrasova; T S Balashova
Journal: Dokl Biol Sci Date: 2015-11-04

2. Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors: Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal: Clin Immunol Date: 2017-09-23 Impact factor: 3.969

3. Recurrence of autoimmunity in pancreas transplant patients: research update.

Authors: Alberto Pugliese; Helena K Reijonen; Jerry Nepom; George W Burke
Journal: Diabetes Manag (Lond) Date: 2011-03

4. Significance of intragraft CD138+ lymphocytes and p-S6RP in pediatric kidney transplant biopsies.

Authors: Eileen W Tsai; William D Wallace; David W Gjertson; Elaine F Reed; Robert B Ettenger
Journal: Transplantation Date: 2010-10-27 Impact factor: 4.939

5. Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes.

Authors: Kevan C Herold; Mark D Pescovitz; Paula McGee; Heidi Krause-Steinrauf; Lisa M Spain; Kasia Bourcier; Adam Asare; Zhugong Liu; John M Lachin; H Michael Dosch
Journal: J Immunol Date: 2011-07-20 Impact factor: 5.422

6. B cell-targeted therapies in autoimmunity: rationale and progress.

Authors: Paolo Fiorina; Mohamed H Sayegh
Journal: F1000 Biol Rep Date: 2009-05-28

7. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.

Authors: Chang-yun Hu; Daniel Rodriguez-Pinto; Wei Du; Anupama Ahuja; Octavian Henegariu; F Susan Wong; Mark J Shlomchik; Li Wen
Journal: J Clin Invest Date: 2007-12 Impact factor: 14.808

8. Tolerant anti-insulin B cells are effective APCs.

Authors: Peggy L Kendall; James B Case; Allison M Sullivan; Jeff S Holderness; K Sam Wells; Edwin Liu; James W Thomas
Journal: J Immunol Date: 2013-02-08 Impact factor: 5.422

9. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.

Authors: A Alba; R Planas; X Clemente; J Carrillo; R Ampudia; M-C Puertas; X Pastor; E Tolosa; R Pujol-Borrell; J Verdaguer; M Vives-Pi
Journal: Clin Exp Immunol Date: 2008-01-08 Impact factor: 4.330

10. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice.

Authors: Ghazal Zekavat; Susan Y Rostami; Armen Badkerhanian; Ronald F Parsons; Brigitte Koeberlein; Ming Yu; Christopher D Ward; Thi-Sau Migone; Liping Yu; George S Eisenbarth; Michael P Cancro; Ali Naji; Hooman Noorchashm
Journal: J Immunol Date: 2008-12-01 Impact factor: 5.422